AJMB  Vol.4 No.1 , January 2014
Study of angiotensin converting enzyme and genotype among Egyptian preeclampsia patients
Abstract: Preeclampsia is a frequent disorder with reported incidence in pregnancies. In Egypt, it complicates 6%-8% of pregnancies and reaches 15% in referral centers. The renin-angiotensin system activation during the early stages of Preeclampsia proved to be a direct cause. Women carrying the D allele of the ACE-I/D polymorphism have higher measures of uterine artery resistance, which is a marker for development of intrauterine growth retardation and preeclampsia. The maternal syndrome of preeclampsia (PE) during the latter half of pregnancy is believed to result from impaired placentation in early gestation and a failure to develop low resistance uteroplacental circulation. Aim: The aim of this study was to evaluate the association with angiotensin converting enzyme gene polymorphism and changes in its enzyme serum level in preeclamptic patients compared to non preeclamptic control group together with studying the changes in umbilical artery and uterine artery Doppler. Subjects: The study was conducted on 180 pregnant women allocated into two groups having the same inclusion and exclusion criteria except for hypertension and proteinuria; each group comprised of 90 pregnant women with matched age. Methods: Doppler study of umbilical and uterine arteries and the detection of Angiotensin converting gene polymorphism by PCR with Estimation of serum ACE in serum by ELISA technique. Results: The distribution of the ACE-I/D genotypes and allelic frequencies in the present study of polymorphism was 37.8% for the DD, 48.9% for the ID, 13.3% for the II in preeclampsia group while it was 33.3% for the DD, 46.7% for the ID, and 20% for the II in the control group. There was no significant difference between cases and controls regarding the cumulative D effect. Conclusions: No existence of a relation between preeclampsia and ACE gene polymorphism considering different modes of inheritance whether is dominance or recessiveness. No effect of ACE gene polymorphism is on ACE serum level. Positive correlation between ACE gene polymorphism and the uterine artery Doppler changes gives strong evidence that ACE gene may have a role in the histopathological changes taking place in these vessels, therefore affecting maternal prognosis. It is unclear to explain this mismatched ACE genetic influence on the incidence of preeclampsia, but the multifactorial pathogenesis of the development and complication in preeclampsia and also physician’s intervention may contribute to the pregnancy outcome. Recommendations: International collaborations, particularly among countries with a high incidence of preeclampsia, may help to include participants with different cultural and genetic backgrounds, which can provide further insight into the etiology of the disease both genetic and environmental.
Cite this paper: Alsokary, H. , Kamel, M. , Sadek, S. , Zakaria, N. and Abdel Fatah, I. (2014) Study of angiotensin converting enzyme and genotype among Egyptian preeclampsia patients. American Journal of Molecular Biology, 4, 26-36. doi: 10.4236/ajmb.2014.41005.

[1]   López-Jaramillo, P., Pradilla, L.P. and Castillo, V.R. (1988) Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. American Journal of Obstetrics & Gynecology, 158, 80-83.

[2]   Lopez-Jaramillo, P., Casas, J.P. and Serrano, N. (2001) Preeclampsia: From epidemiological observations to molecular mechanisms. Brazilian Journal of Medical and Biological Research, 34, 1227-1235.

[3]   Shaaban, M.M. (2006) Hypertensive disorders in pregnancy. Obstetrics Theory and Practice, 1, 173.

[4]   The Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet, 345, 1455-1463.

[5]   Skeggs, L.T., Kahn, J.R. and Shumway, N.P. (1956) Preparation and function of the hypertensin converting enzyme. The Journal of Experimental Medicine, 103, 295-299.

[6]   Broughton Pipkin, F. (1999) What is the place of genetics in the pathogenesis of pre-eclampsia? Biology of the Neonate, 76, 325-330.

[7]   Shah, D.M. (2006) The role of RAS in the pathogenesis of preeclampsia. Current Hypertension Reports, 8, 144-152.

[8]   Mello, G., Parretti, E., Gensini, F., Sticchi, E., Mecacci, F., et al. (2003) Maternal-fetal flow, negative events, and preeclampsia: Role of ACE I/D polymorphism. Hypertension, 41, 932-937.

[9]   Kammerer, C.M., Gouin, N., Samollow, P.B., VandeBerg, J.F., Hixson, J.E., et al. (2004) Two quantitative trait loci affect ACE activities in Mexican-Americans. Hypertension, 43, 466-470.

[10]   Keavney, B., McKenzie, C., Parish, S., Palmer, A., Clark, S., et al. (2000) Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5,000 cases and 6,000 controls. Lancet, 355, 434-442.

[11]   Sayed-Tabatabaei, F.A., Houwing-Duistermaat, J.J., Van Duijn, C.M. and Witteman, J.C. (2003) Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis. Stroke, 34, 1634-1639.

[12]   Bonnici, F., Keavney, B., Collins, R. and Danesh, J. (2002) Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: Meta-analysis of 16 studies. British Medical Journal, 325, 517-520.

[13]   National Institute of Child Health and Development (2001) Conference summary: Amniotic fluid biology-basic and clinical aspects. The Journal of Maternal-Fetal Medicine, 10, 2-19.

[14]   Altman, D.J. and Chitty, L.S. (1993) Design and analysis of studies to derive fetal charts of fetal size. Ultrasound in Obstetrics & Gynecology, 3, 378-384.

[15]   Chudleigh, T. and Thilaganathan, B. (2004) Routine second trimester screening-assessing of gestational age. In: Chudleigh, T. and Thilaganathan, B., Eds., Patricia Obstetric Ultra-Sound: How Why, and When? 3rd Edition, Elsevier Churchil Living Stone, 95-112.

[16]   Figen, G., Elif, B., Hulya, Y., Turgay, S. and Ahmet, D. (2004) The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism. Clinica Chimica Acta, 341, 127-131.

[17]   Roberts, J.M. and Lain, K.Y. (2002) Recent insights into the pathogenesis of pre-eclampsia. Placenta, 23, 359-372.

[18]   Shim, S.S., Shim, J.Y., Lim, J.H., Park, J.S., Jun, J.K., Bai, K.B., Yoon, B.H. and Syn, H.C. (2003) Molecular biological approach to find out the etiology of hypertensive disorder in pregnancy: Analysis of the polymorphism in the promoter of human angiotensinogen gene in Korean population. Korean Journal of Obstetrics & Gynecology, 46, 1486-1492.

[19]   Morise, T., Takeuchi, Y. and Takeda, R. (1995) Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. Journal of Internal Medicine, 237, 175-180.

[20]   Langer, B., Grima, M., Coquard, C., Bader, A.M., Schlaeder, G. and Imbs, J.L. (1998) Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstetrics & Gynecology, 91, 196-202.

[21]   Rasmussen, A.B., Pedersen, E.B., Romer, F.K., Johannesen, P., Kristensen, S., Lauritsen, J.G. and Wohlert, M. (1983) The influence of normotensive pregnancy and pre-eclampsia on angiotensin-converting enzyme. Acta Obstetricia et Gynecologica Scandinavica, 62, 341-344.

[22]   Roh, C.R., Kim, D.K., Yoon, B.K., Yang, S.H., Chung, J.H., Bae, D.S. and Lee, J.H. (1997) A common genetic variant of the angiotensin converting enzyme (ACE) gene and pregnancy induced hypertensive disorders. Korean Journal of Obstetrics & Gynecology, 40, 1189-1199.

[23]   Roberts, C.B., Rom, L., Moodley, J. and Pegoraro, R.J. (2007) Hypertension-related gene polymorphisms in preeclampsia, eclampsia and gestational hypertension in Black South African women. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 131, 115-126.

[24]   Knyrim, E., Muetze, S., Eggermann, T., Rudnik-Schoeneborn, S., Lindt, R., Ortlepp, J.R., Rath, W. and Zerres K. (2008) Genetic analysis of the Angiotensinogen gene in pre-eclampsi. Gynecologic and Obstetric Investigation, 66, 203-208.

[25]   Choi, H., Kang, J.Y., Yoon, H.S., et al. (2004) Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. Journal of Hypertension, 22, 945-948.

[26]   Kobashi, G. (2003) Gene polymorphisms and preeclampsia in Japanese; Analysis for gene-environment interaction. Acta Obstetrica et Gynaecologica Japonica, 55, 817-829 .

[27]   Laskowska, M., Laskowska, K. and Oleszczuk, J. (2002) Angiotensin-converting enzyme activity in pre-eclampsia. International Journal of Gynecology and Obstetrics, 77, 33-34.

[28]   Jacob, H.J., Lindpaintner, K., Lincoln, S.E., Kusumi, K., Bunker, R.K., Mao, Y.P., Ganten, D., Dzau, V.J. and Lander, E.S. (1991) Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell, 67, 213-224.

[29]   Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y.V., Lifton, R.P., Williams, C.S., Charru, A., Hunt, S.C., Hopkins, P.N., Williams, R.R., Lalouel, J.M. and Corvol, P. (1992) Molecular basis of human hypertension: Role of angiotensinogen. Cell, 71, 169-180.

[30]   August, P. and Sealey, J.E. (1990) The renin-angiotensin system in normal and hypertensive pregnancy and in ovarian function. Hypertension; Pathophysiology, Diagnosis, and Management, 1761-1778.

[31]   Yu, C.K., Casas, J.P., Savvidou, M.D., Sahemey, M.K., Nicolaides, K.H., et al. (2006) Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: A case-control study and a metaanalysis. BMC Pregnancy Childbirth, 6, 7.

[32]   Lin, J. and August, P. (2005) Genetic thrombophilias and preeclampsia: A meta-analysis. Obstetrics & Gynecology, 105, 182-192.

[33]   Rumbold, A.R., Crowther, C.A., Haslam, R.R., Dekker, G.A. and Robinson, J.S., ACTS Study Group (2006) Vitamins C and E and the risks of preeclampsia and perinatal complications. New England Journal of Medicine, 354, 1796-1806.

[34]   Hingorani, A.D., Shah, T. and Casas, J.P. (2006) Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk. European Heart Journal, 27, 1261-1263.